Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9892063rdf:typepubmed:Citationlld:pubmed
pubmed-article:9892063lifeskim:mentionsumls-concept:C0302908lld:lifeskim
pubmed-article:9892063lifeskim:mentionsumls-concept:C0036751lld:lifeskim
pubmed-article:9892063lifeskim:mentionsumls-concept:C0020361lld:lifeskim
pubmed-article:9892063lifeskim:mentionsumls-concept:C0184661lld:lifeskim
pubmed-article:9892063lifeskim:mentionsumls-concept:C0680730lld:lifeskim
pubmed-article:9892063lifeskim:mentionsumls-concept:C0034760lld:lifeskim
pubmed-article:9892063lifeskim:mentionsumls-concept:C0016315lld:lifeskim
pubmed-article:9892063lifeskim:mentionsumls-concept:C1148554lld:lifeskim
pubmed-article:9892063lifeskim:mentionsumls-concept:C0043798lld:lifeskim
pubmed-article:9892063lifeskim:mentionsumls-concept:C0332324lld:lifeskim
pubmed-article:9892063pubmed:issue1-2lld:pubmed
pubmed-article:9892063pubmed:dateCreated1999-3-23lld:pubmed
pubmed-article:9892063pubmed:abstractTextA pre-column derivatization method using a fluorogenic reagent, 1,2-diphenylethylenediamine (DPE) was studied for the sensitive HPLC determination of 5-hydroxytryptamine (5-HT) and 5-hydroxyindoleacetic acid (5-HIAA), which are biosubstances used in the diagnosis of several diseases. For the quantitative determination, the biogenic indole compounds were converted to their corresponding fluorescent derivatives with DPE in the presence of potassium hexacyanoferrate (III) at room temperature, and then the derivatives were separated by reversed-phase liquid chromatography with fluorescence detection. The chromatographic detection limits of the fluorescent peaks at a signal-to-noise ratio of 3 were 0.3 fmol for 5-HT and 0.2 fmol for 5-HIAA. The proposed method permits the simultaneous quantification of 5-HT and 5-HIAA at concentrations higher than 2.4 nM in human urine without a clean-up procedure.lld:pubmed
pubmed-article:9892063pubmed:languageenglld:pubmed
pubmed-article:9892063pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9892063pubmed:citationSubsetIMlld:pubmed
pubmed-article:9892063pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9892063pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9892063pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9892063pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9892063pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9892063pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9892063pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9892063pubmed:statusMEDLINElld:pubmed
pubmed-article:9892063pubmed:monthDeclld:pubmed
pubmed-article:9892063pubmed:issn1387-2273lld:pubmed
pubmed-article:9892063pubmed:authorpubmed-author:LeeM KMKlld:pubmed
pubmed-article:9892063pubmed:authorpubmed-author:OhtaKKlld:pubmed
pubmed-article:9892063pubmed:authorpubmed-author:IidaHHlld:pubmed
pubmed-article:9892063pubmed:authorpubmed-author:KaiMMlld:pubmed
pubmed-article:9892063pubmed:authorpubmed-author:NohtaHHlld:pubmed
pubmed-article:9892063pubmed:issnTypePrintlld:pubmed
pubmed-article:9892063pubmed:day11lld:pubmed
pubmed-article:9892063pubmed:volume720lld:pubmed
pubmed-article:9892063pubmed:ownerNLMlld:pubmed
pubmed-article:9892063pubmed:authorsCompleteYlld:pubmed
pubmed-article:9892063pubmed:pagination25-31lld:pubmed
pubmed-article:9892063pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:9892063pubmed:meshHeadingpubmed-meshheading:9892063-...lld:pubmed
pubmed-article:9892063pubmed:meshHeadingpubmed-meshheading:9892063-...lld:pubmed
pubmed-article:9892063pubmed:meshHeadingpubmed-meshheading:9892063-...lld:pubmed
pubmed-article:9892063pubmed:meshHeadingpubmed-meshheading:9892063-...lld:pubmed
pubmed-article:9892063pubmed:meshHeadingpubmed-meshheading:9892063-...lld:pubmed
pubmed-article:9892063pubmed:meshHeadingpubmed-meshheading:9892063-...lld:pubmed
pubmed-article:9892063pubmed:meshHeadingpubmed-meshheading:9892063-...lld:pubmed
pubmed-article:9892063pubmed:meshHeadingpubmed-meshheading:9892063-...lld:pubmed
pubmed-article:9892063pubmed:meshHeadingpubmed-meshheading:9892063-...lld:pubmed
pubmed-article:9892063pubmed:year1998lld:pubmed
pubmed-article:9892063pubmed:articleTitleFluorescence derivatizing procedure for 5-hydroxytryptamine and 5-hydroxyindoleacetic acid using 1,2-diphenylethylenediamine reagent and their sensitive liquid chromatographic determination.lld:pubmed
pubmed-article:9892063pubmed:affiliationSchool of Pharmaceutical Sciences, Nagasaki University, Japan.lld:pubmed
pubmed-article:9892063pubmed:publicationTypeJournal Articlelld:pubmed